⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL215572 | 1.00 | — | — | |
| SCHEMBL4269578 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL406007 | 0.97 | TSHR (0.46) | — | |
| Hydrochloric Acid SCHEMBL215571 | 0.97 | TSHR (0.46) | — | |
| Hydrochloric Acid SCHEMBL4269574 | 0.97 | TSHR (0.46) | — | |
| Hydrochloric Acid SCHEMBL3926493 | 0.95 | TSHR (0.43) | — | |
| Hydrochloric Acid SCHEMBL21612233 | 0.95 | TSHR (0.43) | — | |
| Sulfuric Acid SCHEMBL31066598 | 0.90 | TSHR (0.40) | — | |
| SCHEMBL19123628 | 0.90 | TSHR (0.40) | — | |
| SCHEMBL16150186 | 0.88 | CA12 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 561 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118984715-A | Compositions for the treatment of macular degeneration comprising novel peptides | 韩国视角生物株式会社 | 2024-11-19 | — | — | CN | claimed |
| EP-4450079-A1 | COMPOSITION FOR TREATING MACULAR DEGENERATION COMPRISING NOVEL PEPTIDE | EyebioKorea, Inc. (KR) | 2024-10-23 | — | — | EP | claimed |
| EP-3013340-B9 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | JANSSEN PHARMACEUTICALS INC (US) | 2023-10-04 | — | — | EP | claimed |
| WO-2023113300-A1 | COMPOSITION FOR TREATING MACULAR DEGENERATION COMPRISING NOVEL PEPTIDE | 주식회사 아이바이오코리아 | 2023-06-22 | — | — | WO | claimed |
| EP-3013340-B1 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | JANSSEN BIOPHARMA INC (US) | 2023-06-07 | — | — | EP | claimed |
| CN-115524408-A | Method for detecting related substances in emtricitabine-propofol-tenofovir tablet compound preparation | 成都倍特药业股份有限公司 | 2022-12-27 | — | — | CN | claimed |
| US-11447518-B2 | Phosphoramidates for the treatment of hepatitis B virus | EMORY UNIVERSITY (US) | 2022-09-20 | — | — | US | claimed |
| US-20220048912-A1 | CYCLOBUTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS | JANSSEN PHARMACEUTICA NV (BE) | 2022-02-17 | — | — | US | claimed |
| US-20220033406-A1 | CYCLOPENTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS | Janssen Pharmaceuticals, Inc. | 2022-02-03 | — | — | US | claimed |
| EP-3912984-A1 | 4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV | Janssen BioPharma, Inc. (US) | 2021-11-24 | — | — | EP | claimed |
| US-20130281687-A1 | METHODS OF PREPARING SUBSTITUTED NUCLEOTIDE ANALOGS | VERTEX PHARMACEUTICALS INCORPORATED | 2013-10-24 | — | — | US | claimed |
| WO-2013142525-A1 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | ALIOS BIOPHARMA, INC. (US) | 2013-09-26 | — | — | WO | claimed |
| EP-2619216-A1 | SUBSTITUTED NUCLEOTIDE ANALOGS | Alios Biopharma, Inc. (US) | 2013-07-31 | — | — | EP | claimed |
| WO-2013096680-A1 | SUBSTITUTED PHOSPHOROTHIOATE NUCLEOTIDE ANALOGS | ALIOS BIOPHARMA, INC. (US) | 2013-06-27 | — | — | WO | claimed |
| WO-2013096679-A1 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | ALIOS BIOPHARMA, INC. (US) | 2013-06-27 | — | — | WO | claimed |
| WO-2012040126-A1 | SUBSTITUTED NUCLEOTIDE ANALOGS | ALIOS BIOPHARMA, INC. (US) | 2012-03-29 | — | — | WO | claimed |
| WO-2012040127-A1 | SUBSTITUTED NUCLEOTIDE ANALOGS | ALIOS BIOPHARMA, INC. (US) | 2012-03-29 | — | — | WO | claimed |
| US-20120070411-A1 | SUBSTITUTED NUCLEOTIDE ANALOGS | ALIOS BIOPHARMA, INC. (US) | 2012-03-22 | — | — | US | claimed |
| US-20120071434-A1 | SUBSTITUTED NUCLEOTIDE ANALOGS | ALIOS BIOPHARMA, INC. (US) | 2012-03-22 | — | — | US | claimed |
| EP-2103601-A1 | PROCESS FOR PRODUCTION OF PHENYLALANINE DERIVATIVES HAVING QUINAZOLINEDIONE SKELETONS AND INTERMEDIATES FOR THE PRODUCTION | Ajinomoto Co., Inc. (JP) | 2009-09-23 | — | — | EP | claimed |